Pembrolizumab vs Vancomycin
Pembrolizumab vs Vancomycin: Overview
This comparison examines the pharmacological differences between Pembrolizumab and Vancomycin.
Mechanism of Action
Pembrolizumab: Anti-PD-1 monoclonal antibody restoring anti-tumor immunity.
Vancomycin: Glycopeptide antibiotic inhibiting cell wall synthesis by binding D-Ala-D-Ala terminus of peptidoglycan precursors.
Pharmacokinetics
Half-life: Pembrolizumab — 26 days; Vancomycin — 4-6 hours.
Chemical Properties
Molecular Formula: Vancomycin — C66H75Cl2N9O24.
Molecular Weight: Vancomycin — 1449.2500 g/mol.
Type: Pembrolizumab — Antibody; Vancomycin — Small molecule.